ESSA Pharma Inc (EPIX)
1.835
+0.08
(+4.26%)
USD |
NASDAQ |
Nov 22, 16:00
1.835
0.00 (0.00%)
After-Hours: 19:24
ESSA Pharma Total Assets (Quarterly): 132.67M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 132.67M |
| March 31, 2024 | 137.90M |
| December 31, 2023 | 144.49M |
| September 30, 2023 | 149.12M |
| June 30, 2023 | 153.65M |
| March 31, 2023 | 158.50M |
| December 31, 2022 | 165.00M |
| September 30, 2022 | 169.51M |
| June 30, 2022 | 175.66M |
| March 31, 2022 | 182.61M |
| December 31, 2021 | 191.49M |
| September 30, 2021 | 198.17M |
| June 30, 2021 | 203.52M |
| March 31, 2021 | 210.00M |
| December 31, 2020 | 76.18M |
| September 30, 2020 | 80.57M |
| June 30, 2020 | 38.29M |
| March 31, 2020 | 41.80M |
| December 31, 2019 | 47.36M |
| September 30, 2019 | 54.57M |
| Date | Value |
|---|---|
| June 30, 2019 | 7.072M |
| March 31, 2019 | 9.612M |
| December 31, 2018 | 13.21M |
| September 30, 2018 | 16.02M |
| June 30, 2018 | 18.51M |
| March 31, 2018 | 22.33M |
| December 31, 2017 | 3.433M |
| September 30, 2017 | 5.607M |
| June 30, 2017 | 8.406M |
| March 31, 2017 | 13.74M |
| December 31, 2016 | 15.98M |
| September 30, 2016 | 10.40M |
| June 30, 2016 | 13.67M |
| March 31, 2016 | 17.47M |
| December 31, 2015 | 4.623M |
| September 30, 2015 | 7.540M |
| June 30, 2015 | 7.793M |
| March 31, 2015 | 10.97M |
| December 31, 2014 | 3.981M |
| September 30, 2014 | 4.202M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
38.29M
Minimum
Jun 2020
210.00M
Maximum
Mar 2021
139.81M
Average
153.65M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 549.36M |
| Edesa Biotech Inc | 5.228M |
| Lexaria Bioscience Corp | 10.02M |
| Xenon Pharmaceuticals Inc | 835.90M |
| ImmunoPrecise Antibodies Ltd | 42.81M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.805M |
| Shareholders Equity (Quarterly) | 128.86M |